Refractory neonatal candidemia and high-dose micafungin pharmacotherapy [PDF]
Girija Natarajan +2 more
openalex +1 more source
CLINICAL SAFETY AND EFFICACY OF MICAFUNGIN IN TRANSPLANT RECIPIENTS.
NULL AUTHOR_ID
openalex +1 more source
In Vitro Investigation of the Hepatobiliary Disposition Mechanisms of the Antifungal Agent Micafungin in Humans and Rats [PDF]
Souzan B. Yanni +5 more
openalex +1 more source
The evaluation of efficacy and safety for micafungin in the deep-seated mycosis
松橋 延壽 +7 more
openalex +2 more sources
PIN77 Cost Effectiveness of De-Escalation from Micafungin in the Treatment of Patients with Systemic Candida Infections Compared to Traditional Escalation from Fluconazole [PDF]
R.G. Masterton +4 more
openalex +1 more source
Differential In Vivo Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without FKS Resistance Mutations [PDF]
Maiken Cavling Arendrup +5 more
openalex +1 more source
Expression Turnover Profiling To Monitor the Antifungal Activities of Amphotericin B, Voriconazole, and Micafungin against Aspergillus fumigatus [PDF]
Yanan Zhao +5 more
openalex +1 more source
Antifungal Breakpoints of Non-albicans Candida Clinical Isolates in Vitek-2 Compact [PDF]
Arunava Kali +2 more
doaj +1 more source
Combination effect of meropenem and antifungals against <i>Escherichia coli</i>-<i>Candida albicans</i> dual-species biofilms <i>in vitro</i> and <i>in vivo</i> using a silkworm model. [PDF]
Kurakado S +3 more
europepmc +1 more source

